Skip to main content
. 2010 Oct 28;6(10):e1001168. doi: 10.1371/journal.ppat.1001168

Figure 5. HPIV3 F HRC cholesterol-tagged peptides inhibit cell fusion mediated by HPIV3 HN/F and NiV G/F.

Figure 5

HPIV3 HN/F (A) or NiV G/F (B) co-expressing cells were allowed to fuse with sialic acid receptor-bearing cells (293T) in the presence of increasing concentrations of VIKI-PEG4-chol (circle), V-PEG4-chol (triangle) or V-chol (square) peptide. After 4 hours, the amount of fusion was quantitated using a beta-galactosidase complementation assay as described in Materials and Methods. The percent inhibition of fusion (compared to results for control cells not treated with peptide) is shown as a function of the (log-scale) concentration of peptide. The values are means (± SD) of results from three experiments.